Related Experiment Videos

[Human Metapneumovirus in hospitalized children - a review]

A Wilkesmann1, O Schildgen, A M Eis-Hübinger

  • 1Zentrum für Kinderheilkunde am Universitätsklinikum Bonn.

Klinische Padiatrie
|April 6, 2006
PubMed

Insights

Human Metapneumovirus (HMPV) is a significant cause of severe respiratory infections in young children, often requiring hospitalization. HMPV infections can present with pneumonia, apnea, and mimic bacterial infections, necessitating specific diagnostic tests.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Respiratory Medicine

Context:

  • Human Metapneumovirus (HMPV), identified in 2001, is a key etiological agent of childhood respiratory infections.
  • This review analyzes hospitalized children with HMPV infections from two seasons (2002-2004).

Purpose:

  • To highlight the clinical characteristics and risk factors associated with severe HMPV infections in hospitalized children.
  • To emphasize the diagnostic challenges and the need for specific testing for HMPV.

Summary:

  • Hospitalized children with HMPV often have pre-existing risk factors, leading to severe outcomes like bronchiolitis, pneumonia, and apnea, particularly in premature infants.
  • HMPV infections can manifest as lobar or segmental pneumonias, indistinguishable from bacterial infections, and may rarely be associated with meningoencephalitis.
  • Clinical presentation and radiological findings are insufficient for definitive diagnosis, underscoring the importance of PCR testing for HMPV.

Impact:

  • Informs clinicians about the significant role of HMPV in pediatric respiratory illness, especially in vulnerable populations.
  • Stresses the need for HMPV testing in hospitalized children with respiratory symptoms, including those with asthma or cystic fibrosis exacerbations.
  • Highlights the necessity for further research into HMPV-specific therapies and the prevention of hospital-acquired HMPV infections.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: